当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Nilesh Ingle, NishaKumari Ojha and Abhimanyu Kumar
Respiratory allergic disorders are the most common allergic manifestation that is encountered in paediatric age group. Grievance of this problem is stated by statistical view which shows 5-20% of the paediatric population are sufferers of Respiratory Allergic Disorders (RAD). Acharya charak mentions a variety of hetus for this type of disease that incorporates Rajasa (from dust), Dhooma (smoke), Rukshaanna (dry food), and Vishamashan (irregular diet). These are important causative factors that can be attributed to environment and diet. Because respiratory allergies occur mostly due to hyper responsivenessto these factors in the form of histamine release and activation of mast cells, treatment is aimed towards anti-histaminic and mast cell stabilising agent. Ayurveda has a large number of drugs that can act as anti-histaminic or mast cell stabilising agents. The present paper is focused on Charakokta mahakashaya to determine the role of Shwashar Mahakashaya, Kasahar mahakashaya and Vishaghna mahakashaya and their dravyas for management of RAD. The paper attributes to the critical analysis of Shwashhar, Kasahar, and Vishaghna mahakashaya to elicit their pharmacological actions based on various experimental and clinical studies.